# Core Molding Technologies Inc: overview CMT · NYSE · CIK 1026655 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cmt.md) · [Financials](/companies/cmt/financials.md) · [Filings](/companies/cmt/filings.md) · [Insiders](/companies/cmt/insiders.md) Latest reported revenue: [$62.7m](/filings/0001026655-26-000053.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001026655-26-000053). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [73.0](/filings/0001026655-26-000009.md) | [62.5](/filings/0001026655-26-000009.md) | [61.4](/filings/0001026655-26-000028.md) | [79.2](/filings/0001026655-26-000053.md) | [58.4](/filings/0001026655-26-000009.md) | [74.7](/filings/0001026655-26-000009.md) | [58.6](/filings/0001026655-26-000028.md) | [62.7](/filings/0001026655-26-000053.md) | | Gross margin | % | [16.9%](/filings/0001026655-26-000009.md) | [15.8%](/filings/0001026655-26-000009.md) | [19.2%](/filings/0001026655-26-000028.md) | [18.1%](/filings/0001026655-26-000053.md) | [17.4%](/filings/0001026655-26-000009.md) | [15.2%](/filings/0001026655-26-000009.md) | [20.4%](/filings/0001026655-26-000028.md) | [20.3%](/filings/0001026655-26-000053.md) | | Operating margin | % | [4.9%](/filings/0001026655-26-000009.md) | [1.4%](/filings/0001026655-26-000009.md) | [4.6%](/filings/0001026655-26-000028.md) | [6.6%](/filings/0001026655-26-000053.md) | [4.4%](/filings/0001026655-26-000009.md) | [4.8%](/filings/0001026655-26-000009.md) | [1.3%](/filings/0001026655-26-000028.md) | [3.7%](/filings/0001026655-26-000053.md) | | Net margin | % | [4.3%](/filings/0001026655-26-000009.md) | [(0.1%)](/filings/0001026655-26-000009.md) | [3.6%](/filings/0001026655-26-000028.md) | [5.1%](/filings/0001026655-26-000053.md) | [3.2%](/filings/0001026655-26-000009.md) | [4.1%](/filings/0001026655-26-000009.md) | [1.0%](/filings/0001026655-26-000028.md) | [2.8%](/filings/0001026655-26-000053.md) | | Diluted EPS | $ per share | [0.36](/filings/0001026655-26-000009.md) | [0.00](/filings/0001026655-26-000009.md) | [0.25](/filings/0001026655-26-000028.md) | [0.47](/filings/0001026655-26-000053.md) | [0.22](/filings/0001026655-26-000009.md) | [0.36](/filings/0001026655-26-000009.md) | [0.07](/filings/0001026655-26-000028.md) | [0.21](/filings/0001026655-26-000053.md) | | Free cash flow | $m | [7.0 d](/filings/0001026655-25-000085.md) | [0.5 d](/filings/0001026655-26-000009.md) | [4.3](/filings/0001026655-26-000028.md) | [0.9 d](/filings/0001026655-26-000053.md) | [(0.3) d](/filings/0001026655-25-000085.md) | [(2.9) d](/filings/0001026655-26-000009.md) | [(13.0)](/filings/0001026655-26-000028.md) | [8.0 d](/filings/0001026655-26-000053.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [307](/filings/0001026655-24-000030.md) | [377](/filings/0001026655-25-000005.md) | [358](/filings/0001026655-26-000009.md) | [302](/filings/0001026655-26-000009.md) | [274](/filings/0001026655-26-000009.md) | | Gross margin | % | [13.4%](/filings/0001026655-24-000030.md) | [13.9%](/filings/0001026655-25-000005.md) | [18.0%](/filings/0001026655-26-000009.md) | [17.6%](/filings/0001026655-26-000009.md) | [17.4%](/filings/0001026655-26-000009.md) | | Operating margin | % | [3.6%](/filings/0001026655-24-000030.md) | [4.8%](/filings/0001026655-25-000005.md) | [7.4%](/filings/0001026655-26-000009.md) | [5.5%](/filings/0001026655-26-000009.md) | [5.2%](/filings/0001026655-26-000009.md) | | Net margin | % | [1.5%](/filings/0001026655-24-000030.md) | [3.2%](/filings/0001026655-25-000005.md) | [5.7%](/filings/0001026655-26-000009.md) | [4.4%](/filings/0001026655-26-000009.md) | [4.1%](/filings/0001026655-26-000009.md) | | Diluted EPS | $ per share | [0.55](/filings/0001026655-24-000030.md) | [1.44](/filings/0001026655-25-000005.md) | [2.31](/filings/0001026655-26-000009.md) | [1.51](/filings/0001026655-26-000009.md) | [1.29](/filings/0001026655-26-000009.md) | | Free cash flow | $m | [1.0](/filings/0001026655-24-000030.md) | [2.4](/filings/0001026655-25-000005.md) | [25.7](/filings/0001026655-26-000009.md) | [23.6](/filings/0001026655-26-000009.md) | [1.9](/filings/0001026655-26-000009.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cmt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $11.5m | 485,995 | | Added +13,367 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $10.9m | 461,947 | | Reduced −26,500 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $9.6m | 407,258 | | Added +16,051 | | [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $8.9m | 375,800 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.1m | 343,143 | | Added +1,524 | | [GABELLI FUNDS LLC](/funds/1081407.md) | 2026-06-30 | $7.2m | 306,500 | | Unchanged | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $6.7m | 283,536 | | Added +26,034 | | [22NW, LP](/funds/1694297.md) | 2026-06-30 | $6.5m | 273,521 | | Added +50,783 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $6.0m | 254,059 | | Added +35,029 | | [NEEDHAM INVESTMENT MANAGEMENT LLC](/funds/1167212.md) | 2026-06-30 | $5.7m | 242,600 | | Reduced −9,771 | ## Recent filings [All 998 filings](/companies/cmt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-28 | 10:09 ET | [8-K/A](/filings/0001026655-26-000067.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001026655-26-000067 | | 2026-09-28 | 09:37 ET | [8-K](/filings/0001026655-26-000062.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001026655-26-000062 | | 2026-09-28 | 08:52 ET | [8-K](/filings/0001026655-26-000059.md) | 5.01 Change in control; 9.01 Financial statements and exhibits | 0001026655-26-000059 | | 2026-08-04 | 17:06 ET | [10-Q](/filings/0001026655-26-000053.md) | Quarterly report, period 2026-06-30 | 0001026655-26-000053 | | 2026-08-04 | 08:54 ET | [8-K](/filings/0001026655-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001026655-26-000049 | | 2026-07-07 | 17:22 ET | [8-K](/filings/0001026655-26-000043.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001026655-26-000043 | | 2026-06-08 | 17:11 ET | [8-K](/filings/0001026655-26-000041.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001026655-26-000041 | | 2026-06-05 | 16:29 ET | [8-K](/filings/0001026655-26-000039.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001026655-26-000039 | | 2026-06-04 | 16:17 ET | [8-K](/filings/0001026655-26-000037.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001026655-26-000037 | | 2026-05-19 | 16:37 ET | [8-K](/filings/0001026655-26-000033.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001026655-26-000033 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001026655-26-000009.md), filed Mar 10, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a00ca394-5863-4969-8f86-6c4165d93c61) ## About the filer - CIK: 1026655 - Tickers: CMT - Exchange: NYSE - SIC code: 3089 Plastics Products, NEC - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.